Roberta Pirolo

How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009–2013

Ylenia Ingrasciotta, Francesco Giorgianni, Jenny Bolcato et al. · BioDrugs · 2015 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study

Ylenia Ingrasciotta, Francesco Giorgianni, Ilaria Marcianò et al. · PLoS ONE · 2016 · 40 citations · Full text

Pharmacy, Hematology, Pharmacology +16

How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014

Ilaria Marcianò, Ylenia Ingrasciotta, Francesco Giorgianni et al. · BioDrugs · 2016 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +12